Related Experiment Video
Updated: Aug 9, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Deep sedation with methohexital or thiamylal with midazolam for invasive procedures in children with acute
Ming-Yun Hsieh1, Giun-Yi Hung, Yuh-Lin Hsieh
1Department of Pediatrics, Taipei Veterans General Hospital Taipei, Taiwan.
Insights
Deep sedation using methohexital or thiamylal with midazolam is safe for pediatric acute lymphoblastic leukemia (ALL) patients undergoing invasive procedures. This approach effectively manages anxiety and ensures compliance in young children during treatments.
Area of Science:
- Pediatric Oncology
- Anesthesiology
- Pharmacology
Background:
- Pediatric oncology patients, particularly those with acute lymphoblastic leukemia (ALL), frequently require painful invasive procedures.
- Deep sedation is often necessary for young children to manage anxiety and ensure cooperation during these interventions.
Purpose of the Study:
- To evaluate the clinical safety and efficacy of methohexital or thiamylal combined with midazolam for deep sedation in children with ALL undergoing elective invasive procedures.
Main Methods:
- A retrospective review of 20 pediatric patients with ALL who received deep sedation between November 1997 and March 2004.
- Procedures included intrathecal therapy, with sedation administered using either methohexital or thiamylal alongside midazolam.
- Dosages and adverse events were recorded for analysis.
Main Results:
- A total of 176 procedures were performed, with 139 being intrathecal therapies.
- One procedure failed due to bradycardia, hypotension, and cyanosis in the methohexital group; no other significant adverse events were noted.
- Both sedation regimens resulted in increased heart rate with stable blood pressure.
Conclusions:
- Methohexital or thiamylal combined with midazolam provides a safe deep sedation option for young pediatric ALL patients undergoing invasive procedures.
- Careful monitoring and experienced practitioners are crucial for successful and safe sedation in this vulnerable population.
Abstract:
Pediatric oncology/hematology patients, especially those with acute lymphoblastic leukemia (ALL), often undergo repeated painful invasive procedures. Deep sedation, mandatory for these procedures in young children, can reduce patient anxiety and get their compliance during procedures. This study assessed clinical experience of employing methohexital or thiamylal with midazolam as sedative for elective invasive procedures in children with ALL. Between November 1997 and March 2004, 20 out of 33 ALL children received deep sedation after evaluation, mainly because of relatively young age (mean age 4.60 +/- 2.03 years). A total of 176 procedures were done, with 139 being intrathecal therapy. There were 98 and 78 procedures for the methohexital and thiamylal groups, respectively. The average dosages to complete the procedures were 2.2 +/- 1.2 mg/kg for methohexital and 3.4 +/- 2.1 mg/kg for thiamylal. One out of the 176 procedures was failed due to bradycardia, hypotension and cyanosis, in the methohexital group. Otherwise, no significant adverse events were found. Increased heart rate (HR) during stable blood pressure (BP) was observed in both groups. In conclusion, under careful monitoring and performed by experienced practitioners, the application of methohexital or thiamylal combined with midazolam to achieve deep sedation for invasive procedures in young children with ALL is safe.
Related Concept Videos
Parenteral Anesthetics: Overview
Skeletal Muscle Relaxants: Therapeutic Uses
Stages of General Anesthesia
Local Anesthetics: Clinical Application as Spinal Anesthesia
Inhalational Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
